Evofem Biosciences (EVFM) Shares Outstanding (Entity) (2014 - 2026)
Evofem Biosciences (EVFM) recorded Shares Outstanding (Entity) of 132.53 million in Q2 2026, up 11.7% from 118.66 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
For FY2025, Evofem Biosciences reported Shares Outstanding (Entity) of 126.69 million, up 68.5% from FY2024.
- Annual Shares Outstanding (Entity) has a five-year compound annual growth rate of 95.1% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Entity) came in at 75.2 million in FY2024, 4.83 million in FY2023 (-91.7%), 58.25 million in FY2022 (+567.4%) and 8.73 million in FY2021 (+94.9%).
- On a year-over-year basis, Shares Outstanding (Entity) has increased for six consecutive quarters, with growth averaging 77.4% over the last six quarters.
- Peak year-over-year performance for Shares Outstanding (Entity) in the last five years was growth of 657.9% in Q3 2022, against a decline of 94.9% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 132.53 million (Q1 2026), 126.69 million (Q4 2025) and 126.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | 132.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132.53 Mn |
| Mar 31, 2026 | 132.53 Mn |
| Dec 31, 2025 | 126.69 Mn |
| Sep 30, 2025 | 126.69 Mn |
| Jun 30, 2025 | 118.66 Mn |
| Mar 31, 2025 | 113.36 Mn |
| Dec 31, 2024 | 75.20 Mn |
| Sep 30, 2024 | 100.33 Mn |
| Jun 30, 2024 | 66.77 Mn |
| Mar 31, 2024 | 31.19 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 4.24 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 58.25 Mn |
| Sep 30, 2022 | 82.44 Mn |
| Jun 30, 2022 | 27.13 Mn |
| Mar 31, 2022 | 12.71 Mn |
| Dec 31, 2021 | 8.73 Mn |
| Sep 30, 2021 | 10.88 Mn |
API Access
Evofem Biosciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();